Revolutionizing Healthcare: Aging, AI, and the Future of Medicine – With Jean-Christophe Barland

The CX Iconoclast

Richard Owen and Jean-Christophe Barland discussed the complexities facing the pharmaceutical industry, particularly in relation to healthcare delivery and the aging population. Barland emphasized the diversity among physicians in terms of their engagement with new technologies and their competence, which can lead to varying patient outcomes. A more data-driven, scientific approach could help address these inconsistencies. Internally, pharmaceutical companies must ensure a strong corporate culture to support a better external customer experience.
Barland used the "IKEA effect" as a metaphor, suggesting that when customers are actively involved in complex healthcare processes—just like when they are assembling furniture—they become more invested in the outcomes. This was particularly relevant in the context of cellular therapies, where the precision required is immense, especially in cultures like Japan, where expectations for flawless execution are high. Barland’s experience leading teams in Japan revealed the importance of framing healthcare challenges as collective efforts, fostering deeper customer engagement

The conversation also touched on the economic and societal implications of an aging population. While older adults often become viewed as a financial burden on healthcare systems, Barland suggested that we need to rethink their potential contributions to the workforce. Shifting cultural attitudes, particularly in countries like France, where early retirement is deeply ingrained, is crucial for enabling older adults to remain economically active. Innovations in healthcare are exploding, with AI playing a significant role in accelerating progress. The COVID-19 pandemic highlighted the power of collaboration and transparency in driving vaccine development, showing the potential for similar approaches in the future. Both Owen and Barland expressed optimism about the future of healthcare, noting that the combination of technology and trust could lead to even greater advancements in improving quality of life, especially for aging populations.
Jean-Christophe Barland is a seasoned executive with over two decades of international experience in the pharmaceutical industry. Most recently, he served as the President and CEO of Bristol-Myers Squibb K.K. in Japan, where he played a pivotal role in the company’s strategic transformation and integration with Celgene. Known for his visionary leadership and commitment to innovation, Jean-Christophe has been instrumental in advancing immuno-oncology research and fostering industry-academia collaborations. His tenure at Bristol-Myers Squibb was marked by significant contributions to the company’s growth and its mission to develop life-saving therapies.

Find out how predictive CX analytics can help your business: https://ocxcognition.com/
Follow us on LinkedIn: https://www.linkedin.com/company/ocxcognition/
Connect with Richard Owen on LinkedIn: linkedin.com/in/richard-owen-98ba3